Does Immunotherapy Work for Leiomyosarcoma?

Some of the current ones for leiomyosarcoma are for a type of treatment called immunotherapy. The goal of immunotherapy is to prime your immune system to fight cancer. Immunotherapy medications are already approved to treat several types of cancer, but not leiomyosarcoma.

Do sarcomas respond to immunotherapy?

D. Immunotherapy for sarcoma has some success cases, including the earliest known instances of spontaneous regression, although sarcoma cancer immunology is still largely unknown.

What is the success rate of immunotherapy for sarcoma?

At a median follow-up of 14.7 months, the 6-month progression-free survival (pfs) was 47% (95% confidence interval: 29.2% to 62.8%), and the 12-month pfs was 28%. Best orr was 25%, demonstrated in 8 patients. Of those 8 patients, 6 had asps; an orr of 50.4% was demonstrated in the 11 evaluable patients with asps.